Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025

Page 2 of 14

13. iCAD Inc (NASDAQ:ICAD)

Number of Hedge Fund Holders In Q3 2024: 4

iCAD Inc (NASDAQ:ICAD) is focusing on AI-powered cancer detection and therapy.

The stock is up significantly so far in 2025 due to solid Q4 2024 results. Revenue is expected to reach $5.1 million to $5.3 million. The company had 106 deals, 16 of which were cloud-based, with new and existing customers. It also reported recurring revenue growth at 11% year-over-year, which reached $9.8 million.

Management is scheduled to present at the BTIG MedTech conference in about two weeks. This is already driving a lot of gains as shareholders think that could drive traction.

ICAD stock is up 70.32% year-to-date.

Page 2 of 14